Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (41-50 of 542) with videos related to

Pageof 55
Sort By:
The American Journal of Medicine|September 16, 1991
Infection control: the premier quality assessment program in United States hospitalsR P Wenzel, M A Pfaller
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)R N Jones, M A Pfaller,
Journal of Clinical Microbiology|May 1, 1985
Use of rapid screening tests in processing urine specimens by conventional culture and the AutoMicrobic systemM A Pfaller, F P Koontz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technologyM A Pfaller, L A Herwaldt
Infection Control and Hospital Epidemiology|September 1, 1991
Candida species: emerging hospital bloodstream pathogensR P Wenzel, M A Pfaller
Journal of Clinical Microbiology|April 9, 2005
Unusual fungal and pseudofungal infections of humansM A Pfaller, D J Diekema
Postgraduate Medicine|August 12, 2009
Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999M A Pfaller, R N Jones
Comprehensive Therapy|November 1, 1995
Epidemiology of candidiasisM G Cormican, M A Pfaller
New Horizons (Baltimore, Md.)|August 1, 1996
Role of the microbiology laboratory in monitoring and identifying resistance: use of molecular biologyM A Pfaller, M G Cormican
Diagnostic Microbiology and Infectious Disease|June 1, 1996
Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testingS A Messer, M A Pfaller
Pageof 55

Showing results (41-50 of 542) with videos related to

Sort By:
Pageof 55
The American Journal of Medicine|September 16, 1991
Infection control: the premier quality assessment program in United States hospitalsR P Wenzel, M A Pfaller
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99)R N Jones, M A Pfaller,
Journal of Clinical Microbiology|May 1, 1985
Use of rapid screening tests in processing urine specimens by conventional culture and the AutoMicrobic systemM A Pfaller, F P Koontz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technologyM A Pfaller, L A Herwaldt
Infection Control and Hospital Epidemiology|September 1, 1991
Candida species: emerging hospital bloodstream pathogensR P Wenzel, M A Pfaller
Journal of Clinical Microbiology|April 9, 2005
Unusual fungal and pseudofungal infections of humansM A Pfaller, D J Diekema
Postgraduate Medicine|August 12, 2009
Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999M A Pfaller, R N Jones
Comprehensive Therapy|November 1, 1995
Epidemiology of candidiasisM G Cormican, M A Pfaller
New Horizons (Baltimore, Md.)|August 1, 1996
Role of the microbiology laboratory in monitoring and identifying resistance: use of molecular biologyM A Pfaller, M G Cormican
Diagnostic Microbiology and Infectious Disease|June 1, 1996
Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testingS A Messer, M A Pfaller
Pageof 55